Annual Report and US Securities & Exchange Commission Form 20-F
These reports, filed with the SIX Swiss Exchange in Switzerland and the US Securities and Exchange Commission (SEC) in the US, provide a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. They also disclose our operating and financial results, accompanied by audited annual financial statements.
View the Novartis Form 20-F in XML format in line with requirements of the SEC.
Novartis in Society ESG Report 2020
The Novartis in Society ESG Report details progress on environmental, social and governance topics and demonstrates the company’s commitment in global health and corporate responsibility.
Annual Review 2020
The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2020.
Download the Annual Review: